SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from SRx Health Solutions, Inc. (SRXH) (CIK 0001471727) (SRXH) — Jul 9, 2019

SRx Health Solutions, Inc. (SRXH) (CIK 0001471727)
Date: July 9, 2019 · CIK: 0001471727 · Accession: 0001140361-19-012619

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-161943

Referenced dates: June 17, 2019

Date
July 9, 2019
Author
/s/ Erika L. Weinberg
Form
CORRESP
Company
SRx Health Solutions, Inc. (SRXH) (CIK 0001471727)

Letter

VIA EDGAR TRANSMISSION Division of Corporation Finance Attention: Joseph Klinko and Lily Dang Filed December 21, 2018 Form 8-K filed May 10, 2019 Form 8-K filed May 23, 2019 File No. 333-161943

Dear Mr. Klinko and Ms. Dang:

On behalf of Better Choice Company Inc., a Delaware corporation (the “Company”), this letter is to confirm the receipt of your letter dated June 17, 2019 regarding the review of the above-referenced filings (the “Comments”), and to hereby request an extension of the period of time in which the Company has to respond to the Comments. The Company expects to respond to the Comments on or before July 15, 2019.

If you have any questions or comments with regard to this response or other matters, please call the undersigned at (212) 906-1297.

Very truly yours,
/s/ Erika L. Weinberg

Show Raw Text
CORRESP
1
filename1.htm

      53rd at Third

      885 Third Avenue

      New York, New York  10022-4834

      Tel: +1.212.906.1200  Fax: +1.212.751.4864

      www.lw.com

                FIRM / AFFILIATE OFFICES

                Beijing

                Moscow

                Boston

                Munich

                Brussels

                New York

                Century City

                Orange County

                Chicago

                Paris

                Dubai

                Riyadh

                Düsseldorf

                San Diego

                Frankfurt

                San Francisco

                Hamburg

                Seoul

                Hong Kong

                Shanghai

                Houston

                Silicon Valley

                London

                Singapore

                Los Angeles

                Tokyo

                Madrid

                Washington, D.C.

                Milan

    July 9, 2019

    VIA EDGAR TRANSMISSION

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street, N.E.

    Mail Stop 4720

    Washington, D.C. 20549

    Attention: Joseph Klinko and Lily Dang

                    Re:

                    Better Choice Company Inc.

    Form 10-K for the Fiscal Year ended August 31, 2018

    Filed December 21, 2018

    Form 8-K filed May 10, 2019

    Form 8-K filed May 23, 2019

    File No. 333-161943

    Dear Mr. Klinko and Ms. Dang:

    On behalf of Better Choice Company Inc., a Delaware corporation (the “Company”), this letter is to confirm the receipt of
      your letter dated June 17, 2019 regarding the review of the above-referenced filings (the “Comments”), and to hereby request an extension of the period of time in which the Company has to
      respond to the Comments. The Company expects to respond to the Comments on or before July 15, 2019.

    If you have any questions or comments with regard to this response or other matters, please call the undersigned at (212) 906-1297.

            Very truly yours,

            /s/ Erika L. Weinberg

            Erika L. Weinberg

            of LATHAM & WATKINS LLP

              cc:

                Damian Dalla-Longa, Co-Chief Executive Officer, Better Choice Company Inc.

    Lori Taylor, Co-Chief Executive Officer, Better Choice Company Inc.

    Marc D. Jaffe, Esq., Latham & Watkins LLP

    Ian D. Schuman, Esq., Latham & Watkins LLP